CD39L4 Antibodies

Santa Cruz Biotechnology offers a broad range of CD39L4 monoclonal antibodies for research focused on understanding CD39L4's biological significance. CD39L4 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD39L4, also known as ecto-nucleotide triphosphate diphosphohydrolase 1, plays a crucial role in regulating extracellular nucleotide levels and modulating immune responses. By hydrolyzing ATP and ADP, CD39L4 contributes to the maintenance of tissue homeostasis and influences inflammation and cell signaling pathways. Understanding CD39L4 function is essential for elucidating its potential implications in various diseases, including cancer and autoimmune disorders. Researchers can effectively investigate CD39L4 expression patterns across different tissue types and cellular compartments. Advanced visualization techniques enable detailed examination of CD39L4 localization and interactions with other molecules. Multiple conjugation options are available, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC), allowing for versatile experimental approaches. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of CD39L4's role in health and disease.